1-4 of 4
Marta Vidus Rosin
Close
Sort by
Journal Articles

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

Clinical Trials & Observations
Giovanni Palladini, Ute Hegenbart, Paolo Milani, Christoph Kimmich, Andrea Foli, Anthony D. Ho, Marta Vidus Rosin, Riccardo Albertini, Remigio Moratti, Giampaolo Merlini, Stefan Schönland
Journal: Blood
Blood (2014) 124 (15): 2325–2332.
https://doi.org/10.1182/blood-2014-04-570010
Published: 2014
Includes: Supplemental data
Journal Articles

First Line Therapy With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) In Patients With AL Amyloidosis and Potentially Reversible Contraindications To Autologous Stem Cell Transplant

Giovanni Palladini, MD, PhD, Paolo Milani, MD, Marta Vidus Rosin, MD, Andrea Foli, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2013) 122 (21): 1985.
https://doi.org/10.1182/blood.V122.21.1985.1985
Published: 2013
Journal Articles

Identification Of Reversible Organ Damage and Of Early Markers Of Response To Treatment In Renal AL Amyloidosis: A Study On 461 Patients

Giovanni Palladini, MD, PhD, Paolo Milani, MD, Marta Vidus Rosin, MD, Andrea Foli, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2013) 122 (21): 3087.
https://doi.org/10.1182/blood.V122.21.3087.3087
Published: 2013
Journal Articles

High-Dose Pomalidomide and Dexamethasone Induce Rapid Responses In Patients With AL Amyloidosis Exposed To Alkylators, Immune Modulatory Drugs, and Proteasome Inhibitors

Giovanni Palladini, MD, Paolo Milani, MD, Marta Vidus Rosin, MD, Andrea Foli, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2013) 122 (21): 288.
https://doi.org/10.1182/blood.V122.21.288.288
Published: 2013